IP Library Granted Patent US 10,881,412
Granted Patent B2
US 10,881,412 · App. 16/129,719 · Granted Jan 5, 2021

Method and system for balloon counterpulsation during aortic valve replacement

Inventor: Paul C. Ho (Honolulu, HI)
Assignee: HOCOR Cardiovascular Technologies, LLC
A61B17/12136A61B17/1204A61B17/12118A61F2/2427A61B2017/00703A61F2250/0059A61M25/1011
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,881,412
App. No.
16/129,719
Granted
Jan 5, 2021
Kind
B2
Abstract

Methods and systems for regulating aortic regurgitation during aortic valve replacement or repair procedures utilize a temporary aortic valve (TAV) catheter and a controller. The temporary aortic valve catheter has an expandable occlusion device which can partially occlude the aortic lumen during ventricular diastole with a lesser occlusion during ventricular systole. Exemplary balloon structures include multiple, independently inflatable balloons which are inflated in synchrony with the cardiac cycle by the controller. By controlling aortic regurgitation, the repair or replacement protocols can be conducted with less interference from blood flow.

Claims (22)

1. A method for regulating retrograde aortic blood flow, comprising:

positioning a catheter comprising a tubular body and a variable occlusion device in the ascending aorta above the sinus of Valsalva, the variable occlusion device comprising first and second expandable occlusion elements, wherein the second occlusion element is disposed in parallel with the first occlusion element about the tubular body;

expanding the first and second occlusion elements to partially occlude the aortic lumen about the tubular body of the catheter during ventricular diastole to inhibit retrograde aortic blood flow while allowing perfusion of the coronary arteries via the sinus of Valsalva; and

contracting the first occlusion element while the second occlusion element remains expanded during ventricular systole.

2. A method as in claim 1 , further comprising controlling expansion and contraction of the first and second occlusion elements using a controller.

3. A method as in claim 2 , further comprising performing a replacement or repair procedure.

4. A method as in claim 3 , wherein performing the replacement or repair comprises advancing a replacement valve through a lumen of the catheter.

5. A method as in claim 3 , further comprising removing the native valve, wherein expanding and contracting the occlusion device continues after the valve has been removed.

6. A method as in claim 2 , wherein the controller controls the expansion and contraction of the first occlusion element in synchrony with diastole and systole of a cardiac cycle.

7. A method as in claim 1 , wherein one or more of the first or second occlusion element of the variable occlusion device comprises at least one inflatable element.

8. A method as in claim 1 , wherein one or more of the first or second occlusion element of the variable occlusion device comprises a plurality of independently inflatable elements.

9. A method as in claim 8 , wherein the plurality of inflatable elements are inflated and deflated simultaneously.

10. A method as in claim 8 , wherein individual ones of the elements are inflated while other ones of the elements are deflated.

11. A method as in claim 8 , wherein at least some elements remain inflated at all times to stabilize the occlusion device position within the ascending aorta.

12. A method as in claim 1 , wherein the occlusion device is expanded to occlude from 40% to 90% of the aortic lumen during ventricular diastole and is contracted to reduce occlusion to below 75% of the aortic lumen during ventricular systole.

13. A method as in claim 12 , wherein the occlusion device is contracted to reduce occlusion below 65% during ventricular systole.

14. A method as in claim 12 , wherein the occlusion device is contracted to reduce occlusion below 50% during ventricular systole.

15. A method as in claim 12 , wherein the occlusion device is contracted to reduce occlusion below 25% during ventricular systole.

16. A method as in claim 1 , wherein positioning the catheter comprises advancing the catheter over the aortic arch.

17. A method as in claim 1 , wherein positioning the catheter comprises advancing the catheter transapically.

18. A method as in claim 1 , wherein the first and second occlusion elements are disposed in parallel about a distal end of the catheter.

19. A method as in claim 1 , wherein the first and second occlusion elements are disposed symmetrically about a distal end of the catheter.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2023
From: HO, PAUL C.
To: HOCOR CARDIOVASCULAR TECHNOLOGIES, LLC
Reel/Frame 065475/0691 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2018
From: HO, PAUL C.
To: HOCOR CARDIOVASCULAR TECHNOLOGIES LLC
Reel/Frame 046858/0764 →
Continuity (4)
Continuation 15058999 · Mar 2, 2016
Continuation 13227276 · Sep 7, 2011
Provisional Application 61384989 · Sep 21, 2010
Related Publication 20190069902A1 · Mar 7, 2019
Cited By (1)
US 12,640,270